Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Clinical trial NCT00652184 · UNKNOWN

Trial details

NCT number: NCT00652184
Sponsor: aRigen Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Herpes Zoster Postherpetic Neuralgia

Start date: 2008-03-01
Primary completion: 2009-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.